COVID-19

DCGI grants Emergency Use Authorisation to COVID-19 vaccine Corbevax for children between 12-18 years of age group

Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation to COVID-19 vaccine Corbevax for children between 12-18 years of age group.

The vaccine has been developed by Hyderabad-based pharmaceutical company Biological E Ltd which country’s first indigenously developed Receptor Binding Domain protein sub-unit COVID-19 vaccine. Earlier, the vaccine had received emergency use authorization for the adult population in December last year.

The Corbevax vaccine is administered through an intramuscular route with two doses scheduled 28 days apart and is stored at 2 to 8 degree Celsius temperature.

3 Comments

3 Comments

  1. Pingback: แทงหวย LSM99

  2. Pingback: this link

  3. Pingback: blote tieten

Leave a Reply

Your email address will not be published.

4 − one =

News is information about current events. News is provided through many different media: word of mouth, printing, postal systems, broadcasting, electronic communication, and also on the testimony of observers and witnesses to events. It is also used as a platform to manufacture opinion for the population.

Contact Info

Address:
D 601  Riddhi Sidhi CHSL
Unnant Nagar Road 2
Kamaraj Nagar, Goreagaon West
Mumbai 400062 .

Email Id: [email protected]

West Bengal

Eastern Regional Office
Indsamachar Digital Media
Siddha Gibson 1,
Gibson Lane, 1st floor, R. No. 114,
Kolkata – 700069.
West Bengal.

Office Address

251 B-Wing,First Floor,
Orchard Corporate Park, Royal Palms,
Arey Road, Goreagon East,
Mumbai – 400065.

Download Our Mobile App

IndSamachar Android App IndSamachar IOS App
To Top
WhatsApp WhatsApp us